Full Text View
Tabular View
No Study Results Posted
Related Studies
Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women (ASAP)
This study is currently recruiting participants.
Verified November 2012 by Vifor Inc.
Study NCT01131624   Information provided by Vifor Inc.

First Received on May 25, 2010.   Last Updated on November 13, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Anaemia
Additional conditions recognized in this trial
Anemia
Anemia, Iron-Deficiency
More general conditions related to this trial
Anemia, Hypochromic
Hematologic Diseases
Iron Metabolism Disorders
Metabolic Diseases
Interventions listed in this trial
ferrous sulphate
Ferinject
Additional drug interventions recognized in this trial
Ferric Compounds
Iron
More general drug interventions related to this trial
Growth Substances
Hematinics
Hematologic Agents
Micronutrients
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Trace Elements
Sponsors listed in this trial
Vifor Inc.
Pierrel Research Europe GmbH


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services